cGxP.wire https://validator.w3.org/feed/docs/rss2.html Smith+Nephew Advances Knee Replacement With LANDMARK System C4 Therapeutics Presents Cemsidomide Biomarker Data in Multiple Myeloma Fate Therapeutics Receives $15 Million CIRM Grant for FT819 Ocugen Gains Provisional Approval for OCU400 in The Bahamas Aptar Pharma and Macquarie University Advance Inhaled Biologics Research Merck Gains FDA Label Update for WINREVAIR in PAH AstraZeneca Gains US Priority Review for IMFINZI in MIBC Persevere Therapeutics Doses First Patient in MIROC-1 Evommune to Present EVO301 Phase 2a Data at EADV 2026 Merck Reports Positive Phase 2b/3 BRUNELLO Results for Remigromig Boehringer Ingelheim Expands Rabies Prevention in Zimbabwe Acadia Reports Phase 2 RADIANT Results for Remlifanserin AstraZeneca Trixeo Wins EU Approval for Asthma Treatment Verastem to Present RAMP 201 Biomarker Data at IGCS 2026 Flagship Wins $47M Deal for Next-Gen Medical Countermeasures Revvity Launches CE-IVDR T1D Early Detection Solution Altasciences Supports 4B Healthcare’s RhineX Clinical Advance Cardiol Expands Phase III MAVERIC Trial in Pericarditis Care Innovent Advances Oncology Pipeline With New ESMO 2026 Data! Decoy Therapeutics Corrects Warrant Inducement Announcement Caliway Reports Positive Phase 2 Results for CBL-514 in Dercum Sarepta to Present Neuromuscular Portfolio Data at NMSG 2026 Octant Doses First Patient in Phase 1b/2 OCT-980 Study XtalPi AI Advances Viva-Thera HIV Drug Discovery Program ClorDiSys Advances Cold-Chain Sterilization for Pharma Tampa General Adopts Host-Response Technology for Sepsis Kedrion Wins FDA Orphan Designation for QIVIGY in SPS Lunai Bioworks Expands Parkinson’s Platform With New Tanaist Rise Therapeutics Advances R-5780 Cancer Immunotherapy Trial Bio-Techne Opens Düsseldorf Center for Life Science Innovation Annexon to Present Vonaprument Data From ARCHER II Marea Therapeutics and Lisata to Present MAR001 Phase 2b Data Milestone Enrolls First Canadian Patient in ReVeRA-301 Takeda Highlights Arcotatug and TAK-928 at ESMO 2026 Genentech Reports Positive Interim Phase 3 Sefaxersen Data TriSalus Gains FDA Clearance for TriNav Advance Travere Gains Notice of Allowance for FILSPARI FSGS Patent Sun Pharma Launches Taro-Methylphenidate ER for ADHD AC Immune Reports Positive Week-100 VacSYn Phase 2 Data ANI Gains FDA Approval for Everolimus Oral Suspension Tablets Ionis and Roche Report Positive Phase 3 IgAN Results Oruka Reports Positive Week 28 ORKA-001 Psoriasis Data Adagene Gains NMPA Clearance for ADG138 IND Wave Initiates Phase 2a WVE-007 Combination Trial for Obesity Fullspan Health Launches AIQ for Pharma AI Search Rhythm Gains Health Canada Approval for IMCIVREE in HO Artelo Files Patent for ART27.13 in Obesity Iterion Therapeutics Reports Positive Tegavivint Phase 1b Data Envisagenics and Boehringer Advance Precision Cancer Therapies Biocon Pertuzumab Biosimilar Gains EMA CHMP Recommendation